Weill Cornell Medicine Mar 20 2025 Weill Cornell Medicine researchers found that restricting telehealth prescriptions for opioid use disorder could keep thousands from accessing buprenorphine, a medication that helps people recover from addiction. The study, published March 3 in JAMA Network Open, warns that requiring in-person visits—as had been proposed by the Drug Enforcement Agency (DEA)—may undo the progress made during the COVID-19 pandemic when telehealth increased access to this life-